Lv2
150 积分 2025-09-16 加入
Limertinib: First Approval
15小时前
待确认
Pulmonary Delivery of Dual-Targeted Nanoparticles Improves Tumor Accumulation and Cancer Cell Targeting by Restricting Macrophage Interception in Orthotopic Lung Tumors
1天前
已完结
Targeted delivery of therapeutics to metastatic lung cancer cells using aptamer-conjugated nanoemulsions
2天前
已完结
Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-/immuno-therapy for cancer treatments
7天前
已完结
Telisotuzumab Vedotin: First Approval
13天前
已完结
Zenocutuzumab: First Approval
17天前
已完结
Lipoprotein-inspired In Situ Activatable Photo-Theranostic Nitrobenzoselenadiazole-Cholesterol for Overcoming Glioblastoma
17天前
已完结
M1-macrophage membrane-camouflaged nanoframeworks activate multiple immunity via calcium overload and photo-sonosensitization
18天前
已完结
Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy
21天前
已完结
Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy
21天前
已完结
皖公网安备34019202002308
